About 20 minutes into his 30-minute presentation at the UBS Global Healthcare Conference in New York City last week, William Clarke, chief technology and medical officer for GE Healthcare, presented a slide containing an image of a processed microarray chip.

“The reason GE Healthcare was created is summarized in this slide,” said Clarke, who until April was executive vice president for research and development for Amersham Health.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.